Navigation Links
Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
Date:4/7/2008

- Dr. Kantor joins founding management team to direct ITI's Center for

Critical Path Immunology -

SAN FRANCISCO, April 7, 2008 /PRNewswire/ -- The Immune Tolerance Institute Inc., (ITI) today announced that Aaron B. Kantor, Ph.D. has joined the company in the position of Chief Scientific Officer, reporting to Louis A. Matis, M.D., President and Chief Executive Officer. Prior to joining ITI, Dr. Kantor served as Executive Director of Cell and Molecular Biology for Biomarker Discovery Sciences at Pharmaceutical Product Development, Inc. (PPD), a leading global contract research organization (CRO) providing discovery, development and post-approval services and compound partnering programs for pharmaceutical, biotechnology, medical device, academic and government organizations.

"We are very pleased to have Aaron join the founding management team at ITI, as he brings to the company broad-based expertise in applying a range of bioanalytical technologies to the discovery of biological markers for human diseases," said Dr. Matis. "His extensive record of accomplishments in both academic and industry settings will be invaluable to ITI as we build our Center for Critical Path Immunology and leverage the partnering opportunities for our integrated diagnostic platforms."

Dr. Kantor, 49, has more than 20 years of research and development experience. He joined PPD in 2005 when the company acquired the biomarker business of SurroMed, Inc., where he was a founding scientist and director of cell and molecular biology. At PPD, his work centered on the broad effort to discover biological markers for human diseases using bioanalytical methods including cytometry, immunoassays, proteomics, metabolomics and bioinformatics tools. He supervised an interdisciplinary group of scientists and engineers in this effort and led the development and implementation of a laser scanning cytometry platform for clinical studies. His responsibilities
'/>"/>

SOURCE The Immune Tolerance Institute Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
2. Seneca Valley High School Student Receives Science Award From MedImmune
3. Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial
4. AutoImmune Inc. Reports 2007 Fourth Quarter and Year End Financial Results
5. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
6. Immune system protein starves staph bacteria
7. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
8. MedImmune Submits Biologics License Application to FDA for Motavizumab
9. Peptimmune Announces First Close of Series D Private Financing
10. MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
11. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...NCOUVER, British Columbia, Dec. 1 /PRNewswire-Firs...sidiary of The Dow Chemical Company (NYSE: DOW )...he signing of a research and commercial license op...ences with access to Agrisoma,s proprietary Engine...asis in major food crops, and on a non-exclusive b...
(Date:12/1/2009)...ire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulleti...biopharmaceutical company developing human vaccine...ency Virus) and other infectious agents, today ann...y is the 21st World AIDS Day and as we remember th.../AIDS pandemic, we remain focused and devoted to c...
(Date:12/1/2009)... provides services to three out of top five ,globa... Rochester, NY (PRWEB) December 1, 2009 -- iCa...ced cardiac core lab services and QT analysis, ann...y has selected iCardiac as a preferred vendor of E...y Automated QT(sm) and Dynamic QT beat-to-beat(sm)...
(Date:11/30/2009)... An international team of applied scientists from...demonstrated compact, multibeam, and multi-wavelen...ight spectrum (infrared). By contrast, typical las...elength. The innovative multibeam lasers have pote...al sensing pollution monitoring, optical wireless,...
Breaking Biology Technology:Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Scientists demonstrate multibeam, multi-functional lasers 2
... of Immunosyn Corporation (OTC Bulletin Board: IMY... http://www.wallst.net scheduled for November 16... http://www.wallst.net by 5 P.M. EST,on November...ing Immunosyn,s market potential,growth initiative...at,investors should watch for. "This interview is...
...eported today that it has filed a Form 12b-25 with... that its Form 10-QSB for the six months,ended Sep... 2007. However,AMDL expects to file the required r...y the Rules. Gary L. Dreher, President, stated: "A...ng and we need the additional time to,properly pre...
...e,Company (H&V), a leading global provider of nonw...ision(TM) technology platform, a collaborative,pro...rcialization of,breakthrough products. "HVision w...ed on,creating a new generation of products that e...ry," said Val Hollingsworth, H&V,s President and,C...
Other Biology Technology:WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation 2WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation 3AMDL Announces Filing of Extension on Third Quarter 2007 Form 10-QSB 2H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products 2
(Date:11/30/2009)...ontinue to rise scientists are presented with the ...pond and adapt. In a paper published in Insect Co...Trelles and Dr Miguel Rodriguez assess this challe...ximately 0.6˚C has already affected the Earth...ists and evolutionary biologists is to predict how...
(Date:11/30/2009)...research is the virus,s exquisite specialisation f...ional tools, like the humble lab mouse, can delive...hers writing in BioMed Central,s open access Jour...this problem by creating a mouse that has key feat...HIV. , George Kassiotis, from the Division of Im...
(Date:11/30/2009)...blished in the December 2009 print issue of The F...of control over their fertility that women have ha...found how and where androgenic hormones work in th...le fertility. This opens a promising avenue for th... also offers hope to those who cannot have childre...
Breaking Biology News(10 mins):How can scientists measure evolutionary responses to climate change? 2A reductionist approach to HIV research 2Abbott Declares 343rd Consecutive Quarterly Dividend 14129 1Medical Device Manufacturer MRPC Awarded ISO 13485 Certification 57543 1Medical Device Manufacturer MRPC Awarded ISO 13485 Certification 57543 2Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 1Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 2Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 3
...s at the University of California, San Diego have ... could be used to rapidly screen new drugs for tox...ges of cancer circulating through a patient,s bloo...ue of Langmuir, a physical chemistry journal publi... silicon crystals filled with polystyrene to detec...
...like one of those curiosities which pops up in wil...ould prove a powerful ally for scientists working ... at the University of Edinburgh have discovered th...ar in recent years as a domestic pet ?shares with ...ryonic stem cells to divide without limit. This pr...
...ic expedition to a remote glacier field in Canada,...ets about the beginning of life and provide insigh... team assembled by the University of Calgary,s Arc...weeks studying a sulfur-spewing spring on the surf...is summer, after it was discovered by Institute Ex...
Other Biology News:UCSD researchers develop 'smart petri dish' 2UCSD researchers develop 'smart petri dish' 3Study shows frogs can play key role in stem cell research 2Arctic expedition will investigate alien-like glacier 2
... is critical to the maintenance of appropriate lev...rtant and diverse as those involved in cellular me...presentation, modulation of cell surface receptors...ption, and signalling factors. The ubiquitin-prote...
... is critical to the maintenance of appropriate lev...rtant and diverse as those involved in cellular me...presentation, modulation of cell surface receptors...ption, and signalling factors. The ubiquitin-prot...
...A modified digital scanner serves as the spot-pick...ive standard rack positions on the tray, leaving s...g two racks.,The software allows for manual select...gel image. The individual x,y-coordinates, togethe...
Telomerase ELISA Assay Kit, TRAPEZE from CHEMICON
Biology Products: